Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmy Okello

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Clinical Proteomics|March 23, 2022
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD casesM Taariq Salie, Jing Yang, Carlos R Ramírez Medina, et al.
Global Heart|March 29, 2024
Decentralization and Integration of Advanced Cardiac Care for the World's Poorest Billion Through the PEN-Plus Strategy for Severe Chronic Non-Communicable DiseaseSheila L Klassen, Emmy Okello, Jose M E Ferrer, et al.
Global Heart|July 1, 2024
Correction: Decentralization and Integration of Advanced Cardiac Care for the World's Poorest Billion Through the PEN-Plus Strategy for Severe Chronic Non-Communicable DiseaseSheila L Klassen, Emmy Okello, Jose M E Ferrer, et al.
Circulation. Genomic and Precision Medicine|December 22, 2022
Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†Tafadzwa Machipisa, Chishala Chishala, Gasnat Shaboodien, et al.
JAMA Cardiology|June 9, 2021
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals: Findings From the RHDGen StudyTafadzwa Machipisa, Michael Chong, Babu Muhamed, et al.
European Heart Journal|November 27, 2014
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)Liesl Zühlke, Mark E Engel, Ganesan Karthikeyan, et al.
Circulation|October 6, 2016
Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)Liesl Zühlke, Ganesan Karthikeyan, Mark E Engel, et al.
American Journal of Medical Genetics. Part A|July 28, 2017
Noonan syndrome in diverse populationsPaul Kruszka, Antonio R Porras, Yonit A Addissie, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Clinical Proteomics|March 23, 2022
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD casesM Taariq Salie, Jing Yang, Carlos R Ramírez Medina, et al.
Global Heart|March 29, 2024
Decentralization and Integration of Advanced Cardiac Care for the World's Poorest Billion Through the PEN-Plus Strategy for Severe Chronic Non-Communicable DiseaseSheila L Klassen, Emmy Okello, Jose M E Ferrer, et al.
Global Heart|July 1, 2024
Correction: Decentralization and Integration of Advanced Cardiac Care for the World's Poorest Billion Through the PEN-Plus Strategy for Severe Chronic Non-Communicable DiseaseSheila L Klassen, Emmy Okello, Jose M E Ferrer, et al.
Circulation. Genomic and Precision Medicine|December 22, 2022
Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†Tafadzwa Machipisa, Chishala Chishala, Gasnat Shaboodien, et al.
JAMA Cardiology|June 9, 2021
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals: Findings From the RHDGen StudyTafadzwa Machipisa, Michael Chong, Babu Muhamed, et al.
European Heart Journal|November 27, 2014
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)Liesl Zühlke, Mark E Engel, Ganesan Karthikeyan, et al.
Circulation|October 6, 2016
Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)Liesl Zühlke, Ganesan Karthikeyan, Mark E Engel, et al.
American Journal of Medical Genetics. Part A|July 28, 2017
Noonan syndrome in diverse populationsPaul Kruszka, Antonio R Porras, Yonit A Addissie, et al.
Pageof 17